Skip to main content
. 2023 May 11;39(8):386–393. doi: 10.1097/AJP.0000000000001129

FIGURE 2.

FIGURE 2

Change from baseline in EQ-5D Utility Score during HZ episode by corresponding ZBPI Worst Pain Category and time point. ZOE-50/70 ZOE-HSCT. ZOE-50/70=Placebo participants from the ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) studies who had an HZ episode. ZOE-HSCT=Placebo participants from the ZOE-HSCT study (NCT01610414) who had an HZ episode. EQ-5D=EuroQoL EQ-5D. Pain categories: None=ZBPI Worst pain score=0; Mild Pain=ZBPI pain score=1, 2, 3; Moderate Pain=ZBPI pain score=4, 5, 6, 7; Severe Pain=ZBPI pain score=8, 9, 10. N=Number of participants with a baseline (pre-HZ episode) EQ-5D utility assessment and both an EQ-5D utility and ZBPI worst pain score assessed at the relevant time point during the HZ episode. HSCT indicates hematopoietic stem cell transplantation; HZ, herpes zoster; ZBPI, Zoster Brief Pain Inventory.